暖肝煎联合化疗治疗直肠癌术后患者的临床观察  

Clinical Observation on Nuangan Decoction Combined with Chemotherapy in Treating Rectal Cancer Patients after Operation

作　　者：陈金红 周洁 CHEN Jinhong;ZHOU Jie(Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China)

机构地区：[1]天津中医药大学研究生院,天津300193

出　　处：《中国中医药现代远程教育》2018年第10期112-114,共3页Chinese Medicine Modern Distance Education of China

摘　　要：目的探讨暖肝煎加减联合化疗治疗直肠癌术后气虚血瘀证的疗效。方法选取2015年2月—2017年3月55例直肠癌术后化疗患者,运用随机数字表法将其分为对照组(n=27)与试验组(n=28),对照组予以单纯的化疗,试验组予以暖肝煎联合化疗的使用,2组患者均进行5个疗程的治疗,观察2组患者的临床治疗效果与治疗前后的生活质量评分。结果试验组的临床治疗总有效率与治疗后的生活质量评分分别为96.43%(27/28)与(85.31±7.92)分,对照组的分别为55.56%(15/27)与(75.24±8.07)分,2组比较差异具有统计学意义(P<0.05)。结论暖肝煎加减联合化疗对于改善直肠癌术后患者气虚血瘀症状,减轻患者化疗后骨髓抑制并提升患者的预后生活质量具有一定效果。Objective To explore the therapeutic effect of modified Nuangan decoction combined with chemotherapy in the treatment of qi deficiency and blood stasis syndrome after rectal cancer operation. Methods From February 2015 to March 2017, 55 patients with postoperative chemotherapy of rectal cancer were divided into control group（ n = 27） and experimental group（ n = 28）. The control group was given simple chemotherapy. The experimental group was given modified Nuangan decoction combined with chemotherapy. Results The total effective rate and quality of life score were 96.43 % and（ 85.31 ± 7.92） respectively in the experimental group and 55.56 % and（75.24± 8.07） respectively in the control group, and the difference was statistically significant（ P 0.05）. Conclusion Modified Nuangan decoction combined with chemotherapy can improve the symptoms of qi deficiency and blood stasis in patients with rectal cancer, reduce bone marrow suppression and improve the prognosis of patients with quality of life.

关 键 词：暖肝煎 直肠癌术后 化疗 骨髓抑制 

分 类 号：R735.37[医药卫生—肿瘤]